CompletedNot applicableNCT04007458
Official study title

Maine Lung Cancer Coalition: Using CHWs for the Annual Lung Cancer Screening Reminder

Study summary

This research study will test whether support from a Community Health Worker (CHW) to address barriers to annual LDCT screening will result in an increased number of patients who receive the annual screening as per the recommended standard of care compared to passive outreach using a reminder letter.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedLetter and Community Health Worker Phone Call

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Nov 30, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Anne Conners

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Anne Conners
Interventions being studied
Behavioral: Letter; Behavioral: Community Health Worker Phone Call
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 30 or more pack years of tobacco use
  • If no longer using tobacco, no more than 15 years since last use
  • At least 13 months since last low dose CT scan screening
Reasons someone may not be able to joinExclusion criteria
  • Development of serious medical condition that would preclude treatment of lung cancer if found
  • Death since baseline screen

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • MaineGeneral Medical CenterAugusta, Maine

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 30, 2020. Always confirm current availability with the study team.

View original record ↗